Welcome to LookChem.com Sign In|Join Free
  • or
4-[(cyclopropylmethyl)amino]-3-(trifluoromethyl)benzonitrile is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

821777-30-4

Post Buying Request

821777-30-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

821777-30-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 821777-30-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,2,1,7,7 and 7 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 821777-30:
(8*8)+(7*2)+(6*1)+(5*7)+(4*7)+(3*7)+(2*3)+(1*0)=174
174 % 10 = 4
So 821777-30-4 is a valid CAS Registry Number.

821777-30-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(cyclopropylmethylamino)-3-(trifluoromethyl)benzonitrile

1.2 Other means of identification

Product number -
Other names Benzonitrile,4-[(cyclopropylmethyl)amino]-3-(trifluoromethyl)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:821777-30-4 SDS

821777-30-4Upstream product

821777-30-4Downstream Products

821777-30-4Relevant academic research and scientific papers

PHARMACEUTICAL COMPOSITION FOR INHIBITING THE ACCUMULATION OF AMYLOID- B PROTEIN

-

, (2010/08/07)

The present invention provides: a pharmaceutical composition for inhibiting amyloid-β protein accumulation comprising a compound of the formula (I) or a pharmaceutically acceptable salt thereof; a method for inhibiting amyloid-β protein accumulation, comprising a step of administering an effective amount of the compound of the formula (I) or a pharmaceutically acceptable salt thereof to a mammal which may be diagnosed with an amyloid-β protein-related disease; and so on.

CHEMICAL COMPOUNDS

-

Page/Page column 111, (2010/11/08)

This invention relates to non-steroidal compounds that are modulators of androgen, glucocorticoid, mineralocorticoid, and progesterone receptors, and also to the methods for the making and use of such compounds.

CHEMICAL COMPOUNDS

-

Page 50, (2010/02/10)

This invention relates to non-steroidal compounds that are or are believed to be modulators of androgen, glucocorticoid, mineralocorticoid, and progesterone receptors, and also to the methods for the making and use of such compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 821777-30-4